{"text_format":"2","workbook":"xls","n_sheets":1,"sheets":["report2"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":1,"defined_names":2,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"report2","index":0,"n_rows":36,"n_cols":5,"rows_kept":36,"cut":false,"hidden":false,"merged":[[0,2,0,3],[0,4,0,5],[1,2,1,3],[1,4,1,5],[2,2,2,3],[2,4,2,5],[3,2,3,3],[4,2,4,3],[5,2,5,3],[6,2,6,3],[8,2,8,3],[9,2,9,3],[11,2,11,3],[11,4,11,5],[12,2,12,3],[12,4,12,5],[13,2,13,3],[13,4,13,5],[14,2,14,3],[15,2,15,3],[18,2,18,3],[19,2,19,3],[20,2,20,3],[21,2,21,3],[27,2,27,3],[28,2,28,3],[31,2,31,3]],"flags":["formulas_cached_only"]}
[null,"1.","Record Nr.",null,"UNISALENTO991003847109707536"]
[null,null,"Autore",null,"De Raho, Francesco"]
[null,null,"Titolo",null,"Tarantolismo : nella superstizione e nella scienza / Francesco De Raho"]
[null,null,"Pubbl/distr/stampa",null,"Lecce : Dante Alighieri, 1908"]
[null,null,"Descrizione fisica",null,"114 p. ; 21 cm"]
[null,null,"Disciplina",null,"398.3530"]
[null,null,"Soggetti",null,"Tarantismo - Salento"]
[{"$nulls":4},"Salento Tarantismo"]
[null,null,"Lingua di pubblicazione",null,"Italiano"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,"2.","Record Nr.",null,"UNISA996339091403316"]
[null,null,"Autore",null,"Kristensen S. D. <1955->"]
[null,null,"Titolo",null,"Therapeutic Strategies in Thrombosis [[electronic resource]]"]
[null,null,"Pubbl/distr/stampa",null,"Oxford, : Atlas Medical Publishing Ltd, 2005"]
[null,null,"ISBN",null,"1-280-30995-4"]
[{"$nulls":4},"9786610309955"]
[{"$nulls":4},"1-84692-543-6"]
[null,null,"Descrizione fisica",null,"1 online resource (405 p.)"]
[null,null,"Collana",null,"Therapeutic Strategies"]
[null,null,"Disciplina",null,"616.13506"]
[null,null,"Soggetti",null,"Thrombolytic therapy"]
[{"$nulls":4},"Thrombosis -- Treatment"]
[{"$nulls":4},"Thrombosis"]
[{"$nulls":4},"Cardiovascular Diseases"]
[{"$nulls":4},"Medicine"]
[{"$nulls":4},"Health & Biological Sciences"]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,null,"Note generali","Description based upon print version of record."]
[null,null,"Nota di contenuto",null,"Contents; Contributors; 1. Arterial thrombosis: a brief overview; 2. Aspirin: a risk-based strategy; 3. Clopidogrel and other platelet ADP inhibitors; 4. Glycoprotein IIb/IIIa inhibitors; 5. Unfractionated heparin and low-molecular-weight heparin in coronary heart disease; 6. Intravenous direct thrombin inhibition: acute coronary syndromes and heparin-induced thrombocytopaenia; 7. Direct thrombin inhibition during percutaneous coronary interventions; 8. Pentasaccharide and other factor Xa inhibitors"]
[{"$nulls":4},"9. Direct thrombin inhibition - thromboprophylaxis, deep venous thrombosis, atrial fibrillation and coronary artery disease10. Warfarin after acute myocardial infarction; 11. Thrombolytic therapy and concomitantantithrombotic therapy; 12. Pre-hospital reperfusion therapy; 13. Antithrombotic strategies in patients undergoing primary percutaneous intervention; 14. Antithrombotic management in patients with prosthetic valves; 15. Stroke: thrombolysis and antithrombotic therapy; 16. Atrial fibrillation: antithrombotic therapy; 17, Venous thromboembolism: pathophysiology and diagnosis"]
[{"$nulls":4},"18. Antithrombotic therapy in venous thrombosis and pulmonary embolism19.Prevention and treatment of venous and arterial "]
[{"$nulls":4},"thrombosis in patients with specific conditions: diabetes, hypercoagulable states, pregnancy and renal diseases; 20. Monitoring of antithrombotic drugs; Index"]
[null,null,null,"Sommario/riassunto","In this new volume, leading authorities from around the world provide an evidence-based review of the therapeutic options currently available for the management of thrombosis. Topics covered include the use of aspirin for primary and secondary prophylaxis, platelet inhibitors, glycoprotein IIb and IIa inhibitors, pentasaccharides, warfarin, and other agents. Other sections discuss the implementation of antithrombotic therapy in managing specific clinical conditions such as pulmonary embolism, atrial fibrillation, stroke and diabetes, or as an adjunct to other procedures such as PCI."]